2017
DOI: 10.1128/aac.01968-16
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Oritavancin on Coagulation Tests in the Clinical Laboratory

Abstract: Previous studies have shown that some lipoglycopeptide and lipopeptide antimicrobial agents may cause falsely elevated values for some phospholipiddependent coagulation tests. The effect of oritavancin, a lipoglycopeptide antibiotic, on coagulation test results was explored using pooled human plasma samples spiked with drug and in a clinical study after an infusion of a single 1,200-mg intravenous dose of oritavancin in normal healthy volunteers. Pooled plasma with oritavancin added ex vivo showed concentratio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 10 publications
0
5
0
Order By: Relevance
“…Oritavancin has also been shown to impact other coagulation tests such as a concentration-dependent prolongation of prothrombin time/international normalized ratio and dilute Russell viper venom time for detecting lupus anticoagulants. 24 Previous studies have highlighted the potential for false vancomycin concentrations in vancomycin TDM, 25,26 including one study in which a patient had an elevated vancomycin concentration before initiation of therapy. 27 Other studies have highlighted the impact of renal function on accumulation of the metabolite, CDP-1, that can also falsely increase vancomycin concentrations.…”
Section: Discussionmentioning
confidence: 99%
“…Oritavancin has also been shown to impact other coagulation tests such as a concentration-dependent prolongation of prothrombin time/international normalized ratio and dilute Russell viper venom time for detecting lupus anticoagulants. 24 Previous studies have highlighted the potential for false vancomycin concentrations in vancomycin TDM, 25,26 including one study in which a patient had an elevated vancomycin concentration before initiation of therapy. 27 Other studies have highlighted the impact of renal function on accumulation of the metabolite, CDP-1, that can also falsely increase vancomycin concentrations.…”
Section: Discussionmentioning
confidence: 99%
“…Upon administration, Dalbavancin tightly binds to the D-ala-D-ala portion of peptidoglycan chains, a site different from that of penicillins and cephalosporins, preventing peptidoglycan elongation and interfering with bacterial cell wall synthesis. This fact leads to bacterial cell death [ 85 ].…”
Section: Lipoglycopeptidesmentioning
confidence: 99%
“…Some lipoglycopeptide antibiotics active against methicillinresistant Staphylococcus aureus (MRSA) such as daptomycin, telavancin, or other lipoglycopeptides may cause prolongation of the aPTT and/or PT and concentration-dependent lack of correction upon mixing with NPP. [17][18][19] In addition, certain PEGylated drugs may cause prolongation of the aPTT depending on the type of PEG and the aPTT reagent used. 20,21 C-reactive protein, a protein produced in the liver and elevated in inflammatory conditions, has also been reported to factitiously prolong the aPTT in certain reagents.…”
Section: Patient Historymentioning
confidence: 99%
“…Exogenous inhibitors include some anticoagulant drugs and certain antibiotics effective against MRSA. 14,15,[17][18][19] The anticoagulant agents that have in vivo inhibitor effects often have a corresponding in vitro effect resulting in prolonged clotting times and include heparins, hirudin-based anticoagulants, parenteral DTIs, and direct oral anticoagulants. 14,15 These typically yield noncorrection in mixing tests, but there should be no need for a mixing test if the history of drug administration is known.…”
Section: Factor Deficiency(ies)mentioning
confidence: 99%